← Back

Pharosyn

London, United Kingdom

seed$2.8M raisedFreshly fundedAI & MLDigital HealthBiotech

Total Raised

$2.8M

Stage

seed

Location

London, United Kingdom

Founded

2025

Team size

1-10

Links

About Pharosyn

Pharosyn is an AI-powered competitive intelligence platform specifically designed for the biopharma industry.

What sets it apart

It combines AI-driven monitoring, filtering, and report generation to deliver biopharma-specific competitive intelligence tailored to each company's pipeline and decision needs.

Sectors

AI & MLDigital HealthBiotechEnterprise SoftwareAI Infrastructure

Business

ModelSaaS

CustomerBiopharma companies, including pharma and biotech commercial strategy, competitive intelligence, portfolio strategy, business development and licensing, market research, and forecasting teams

Notable

  • Raised $3M seed funding in September 2026
  • Backed by Moonfire Ventures, Entrepreneurs First, Transpose Platform, and General Advance
  • Partnered with Eradigm Consulting to improve CI workflow delivery
  • Claims to reduce strategic pharma report turnaround time by over 90%

Funding rounds

seed$2.8M

2 Sept 2026

Led by Moonfire

With Entrepreneurs First, Transpose Platform, General Advance

Source ↗

Explore the market

FAQ

What does Pharosyn do?

Pharosyn is an AI-powered competitive intelligence platform specifically designed for the biopharma industry.

Where is Pharosyn based?

Pharosyn is based in London, United Kingdom, founded in 2025.

How much has Pharosyn raised?

Pharosyn has raised $2.8M in tracked funding and is currently at the seed stage.

Who has invested in Pharosyn?

Investors in Pharosyn include Moonfire Ventures, Entrepreneurs First, Transpose Platform and General Advance.